临床药师参与一例多重耐药的鲍曼不动杆菌肺部感染患者的药物治疗实践

CLINICAL PHARMACISTS PARTCIPATED IN THE DRUG TREATMENT PRACTICE OF A PATIENT WITH PULMONARY INFECTION CAUSED BY MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII

目的通过参与多重耐药鲍曼不动杆菌引起肺部感染的老年患者的药物治疗实践,探讨临床药师参与治疗团队提供药学服务的方向与模式。方法临床药师全程参与多重耐药鲍曼不动杆菌肺部感染老年患者药物治疗并进行临床分析,结合相关指南和文献报道,评估患者临床症状及痰培养药敏结果,优化抗菌药物治疗方案,提供药学监护及用药教育等药学服务。结果临床药师参与治疗2周后,患者体温正常,咳嗽、气喘等症状基本得到控制,治疗过程中未发生相关药物不良反应。结论临床药师利用自身专业知识,结合临床思维参与临床治疗,以保证患者用药的安全性和有效性。

Objective By participating in the drug treatment practice of elderly patients with pulmonary infection caused by pan-drug-resistant Acinetobacter baumannii,we can explore the direction and mode of clinical pharmacists participating in the treatment team and provide pharmacy services.Methods The clinical pharmacist is involved in the whole process of drug treatment and clinical analysis of elderly patients with pan-drug-resistant Acinetobacter baumannii pulmonary infection.Combined with relevant guidelines and literature reports,evaluated patients'clinical symptoms and the results of the sputum culture,they optimize antibacterial drug treatment plans and provide pharmaceutical services such as pharmacy monitoring and drug education.Results After the clinical pharmacist participated in the treatment for 2 weeks,the patient's body temperature was normal,cough,asthma and other symptoms were basically controlled,and no related adverse drug reactions occurred during the treatment.Conclusions Clinical pharmacists use their professional characteristics to participate in clinical treatment by combining clinical thinking in order to ensure safe and effective medication for patients.